Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Per Karlsson

Professor/ chief physician

Per Karlsson
Professor/ chief physician
per.karlsson@oncology.gu.se
+46 31-342 1000

Postal Address: Sahlgrenska universitetssjukhuset, 41345 Göteborg
Visiting Address: Blå stråket 2 su/jubileusklin , 41345 Göteborg


Department of Oncology at Institute of Clinical Sciences (More Information)
Sahlgrenska Universitetssjukhuset
413 45 Göteborg
0313428503
Visiting Address: Blå stråket 2 SU/Jubileusklin , 413 45 Göteborg

About Per Karlsson

Head of the Department of Oncology

Latest publications

Clinicogenomic Radiotherapy Classifier Predicting the Need for Intensified Locoregional Treatment After Breast-Conserving Surgery for Early-Stage Breast Cancer.
Martin Sjöström, S Laura Chang, Nick Fishbane, Elai Davicioni, Shuang G Zhao et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Journal article 2019
Journal article

Integration of biological factors in the treatment plan evaluation in breast cancer radiotherapy
Henrik Svensson, Dan Lundstedt, Maria Hällje, Magnus Gustafsson, Roumiana Chakarova et al.
Physics and Imaging in Radiation Oncology, Journal article 2019
Journal article

Distribution of locoregional breast cancer recurrence in relation to postoperative radiation fields and biological subtypes.
Jamila Adra, Dan Lundstedt, Fredrika Killander, Erik Holmberg, Mahnaz Haghanegi et al.
International journal of radiation oncology, biology, physics, Journal article 2019
Journal article

---Comprehensive transcriptomic profiling identifies breast cancer patients who may be spared adjuvant systemic therapy.
Martin Sjöström, S Laura Chang, Nick Fishbane, Elai Davicioni, Linda Hartman et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, Journal article 2019
Journal article

Effect of Radiotherapy After Breast-Conserving Surgery Depending on the Presence of Tumor-Infiltrating Lymphocytes: A Long-Term Follow-Up of the SweBCG91RT Randomized Trial.
Anikó Kovács, Axel Stenmark Tullberg, Elisabeth Werner Rönnerman, Erik Holmberg, Linda Hartman et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Journal article 2019
Journal article

Showing 71 - 80 of 110

2011

Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers.
Amanda B Spurdle, Louise Marquart, Lesley McGuffog, Sue Healey, Olga Sinilnikova et al.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Journal article 2011
Journal article

Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2.
A Osorio, R L Milne, R Alonso, G Pita, P Peterlongo et al.
British journal of cancer, Journal article 2011
Journal article

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.
Antonis C Antoniou, Christiana Kartsonaki, Olga M Sinilnikova, Penny Soucy, Lesley McGuffog et al.
Human molecular genetics, Journal article 2011
Journal article

Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.
Susan J Ramus, Christiana Kartsonaki, Simon A Gayther, Paul D P Pharoah, Olga M Sinilnikova et al.
Journal of the National Cancer Institute, Journal article 2011
Journal article

Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA study.
Andersson Michael, Elisabeth Lidbrink, Karsten Bjerre, Erik Wist, Kristin Enevoldsen et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Review article 2011
Review article

Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy.
Per Karlsson, Bernard F Cole, Marco Colleoni, Mario Roncadin, Boon H Chua et al.
International journal of radiation oncology, biology, physics, Journal article 2011
Journal article

2010

Showing 71 - 80 of 110

Page Manager: Katarina Olinder Eriksson|Last update: 3/28/2013
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?